NCT00003020View on ClinicalTrials.gov

LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

September 30, 2000

Study Completion Date

September 30, 2000

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL

LMB-7 immunotoxin

Trial Locations (2)

19107

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER

NCT00003020 - LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases | Biotech Hunter | Biotech Hunter